/

Empresas

As

No verificado

AstraZeneca

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

98 Comunicados de prensa

Ver todos los comunicados de prensa

10/03/2026

AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer

Fuente

Editor

1.00

0

09/03/2026

Mercado laboral

Industria

Ciencia

Higiene alimentaria

Medicina - Varios

Biotecnología

Sanidad

Farmacéutica

Salud

Oncología

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer

Fuente

Editor

1.00

0

20/02/2026

Biotecnología

Higiene alimentaria

Sanidad

Salud

Farmacéutica

Oncología

Ciencia

Medicina - Varios

Industria

CALQUENCE® plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukemia in the 1st-line setting

Fuente

Editor

1.00

0

13/02/2026

Salud

Sanidad

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Industria

Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine

Fuente

Editor

1.00

0

11/02/2026

Biotecnología

Farmacéutica

Sanidad

Salud

Asociaciones/Profesionales

Voluntariado/Solidaridad/ONGs

AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US

Fuente

Editor

1.00

0

10/02/2026

Biotecnología

Farmacéutica

Salud

Web y redes sociales

Telefonía

Mercado de valores

AstraZeneca results: FY and Q4 2025

Fuente

Editor

1.00

0

03/02/2026

Industria

Ciencia

Higiene alimentaria

Medicina - Varios

Biotecnología

Sanidad

Farmacéutica

Salud

Oncología

DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy

Fuente

Editor

1.00

0

02/02/2026

Biotecnología

Sanidad

Farmacéutica

Salud

Industria

AstraZeneca begins trading on the New York Stock Exchange

Fuente

Editor

1.00

0

08/01/2026

Salud

Industria

Ciencia

Farmacéutica

Biotecnología

Mercado laboral

Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit

Fuente

Editor

1.00

0

22/12/2025

Ciencia

Higiene alimentaria

Medicina - Varios

Biotecnología

Salud

Farmacéutica

Sanidad

Oncología

Industria

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0